JNJ-9892
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 08, 2025
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Janssen Research & Development, LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
1 to 1
Of
1
Go to page
1